Skip to content
DataLookout
Menu

NCT02402244

Project: Every Child for Younger Patients With Cancer

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 2 years later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

The 50 most recent of 51 versions: 47 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Dec 31, 2030 to Dec 31, 2032
    • Eligibility criteria expanded, about 20 words
    • Study sites revised (279)
  2. Minor Study sites: 278 to 279v50
  3. Minor Study sites revised (278)v49
  4. Minor Study sites: 276 to 278v48
  5. Minor Study sites: 275 to 276v47
Show 42 earlier versionsHide 42 earlier versions
  1. Minor Study sites: 274 to 275v46
  2. Minor Study sites: 273 to 274v45
  3. Minor Study sites: 242 to 273v44
  4. Minor Study sites revised (242)v43
  5. Notable Enrollment target: 33000 to 75000v42 Show 4 more changesShow less
    • Eligibility criteria expanded, about 14 words
    • Study description expanded, about 98 words
    • Study sites revised (242)
    • Study arms: 1 to 2
  6. Minor Site contacts updated at 2 of 242 sitesv41
  7. Minor Study sites revised (242)v40
  8. Minor Study sites revised (242)v39
  9. Minor Study sites revised (242)v38
  10. Minor Site details revised at 1 of 242 sitesv37
  11. Minor Site details revised at 10 of 242 sitesv36
  12. Notable Eligibility criteria expanded, about 14 words
    • Start date: Oct 26, 2015 to Nov 3, 2015
    • Site contacts updated at 1 of 242 sites
    v35
  13. Notable Primary and study completion dates: Dec 31, 2025 to Dec 31, 2030v34
  14. Minor Study sites revised (242)v33
  15. Minor Site details revised at 2 of 242 sitesv32
  16. Minor Study sites: 241 to 242v31
  17. Minor Site details revised at 9 of 241 sitesv30
  18. Minor Site details revised at 6 of 241 sitesv29
  19. Minor Study sites revised (241)
    • Study description expanded, about 2 words
    v28
  20. Minor Study sites: 240 to 241v27
  21. Minor Site details revised at 1 of 240 sitesv26
  22. Minor Study sites: 239 to 240v25
  23. Minor Site details revised at 11 of 239 sitesv24
  24. Minor Site details revised at 15 of 239 sitesv23
  25. Minor Study sites: 238 to 239v22
  26. Minor Study sites: 237 to 238
    • Study completion date: Dec 31, 2025
    v21
  27. Minor Site details revised at 13 of 237 sitesv20
  28. Minor Study sites: 236 to 237v19
  29. Minor Site details revised at 13 of 236 sitesv18
  30. Minor Site details revised at 11 of 236 sitesv17
  31. Minor Study sites revised (236)v16
  32. Minor Site details revised at 10 of 236 sitesv15
  33. Minor Study sites: 235 to 236v14
  34. Notable Primary endpoint revised
    • Study sites revised (235)
    v13
  35. Notable Primary completion date: Dec 14, 2020 to Dec 31, 2025
    • Study sites: 228 to 235
    • Eligibility criteria revised
    • Study description shortened, about 2 words
    v12
  36. Minor Study sites revised (228)v11
  37. Minor Study sites: 224 to 228v10
  38. Notable Trial status: Active, Not Recruiting to Recruitingv9 Show 6 more changesShow less
    • Primary completion date: Jan 2100 to Dec 14, 2020
    • Eligibility criteria expanded, about 108 words
    • Primary endpoint revised
    • Study sites: 211 to 224
    • Start date: Oct 2015 to Oct 26, 2015
    • Interventions: cytology specimen collection procedure (Other) to Cytology Specimen Collection Procedure (Other), Medical Chart Review (Other)
  39. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 211 of 211 sites
    v8
  40. Minor Site details revised at 7 of 211 sitesv7
  41. Minor Study sites: 1 to 211v6
  42. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jun 2015 to Oct 2015
    • Site details revised
    v3
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Number of patients who consented to biobanking
Timeframe: Baseline

Arms and interventions

Observational Project AYA Protocol

Patients undergo collection of biospecimen samples (e.g., tissue, blood, bone marrow, plasma, serum, buccal swab, saliva, cerebrospinal fluid, or urine).

Observational Project: Every Child Protocol

Patients undergo medical data review to create a Childhood Cancer Registry. Patients also undergo collection of biospecimen samples (e.g., tissue, blood, bone marrow, plasma, serum, buccal swab, saliva, cerebrospinal fluid, or urine).

Other: Cytology Specimen Collection Procedure, Medical Chart Review

Sites

279 sites in 6 countries

United States 246, Canada 17, Australia 10, Puerto Rico 3, New Zealand 2, Saudi Arabia 1